Reply to Slogrove et al.

Autor: Goetghebuer T; Department of Pediatrics, Hôpital Saint-Pierre, Brussels., Smolen KK; Institute for Medical Immunology, Université libre de Bruxelles, Charleroi, Belgium., Adler C; Department of Pediatrics, Hôpital Saint-Pierre, Brussels., Das J; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts., McBride T; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas., Smits G; Department of Pediatrics, Baylor College of Medicine, Houston, Texas., Lecomte S; Institute for Medical Immunology, Université libre de Bruxelles, Charleroi, Belgium., Haelterman E; Department of Pediatrics, Hôpital Saint-Pierre, Brussels., Barlow P; Department of Obstetrics and Gynecology, Hôpital Saint-Pierre, Brussels, Belgium., Piedra PA; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas.; Department of Pediatrics, Baylor College of Medicine, Houston, Texas., Van der Klis F; National Institute of Health and the Environment, Bilthoven, The Netherlands., Kollmann TR; Division of Infectious Diseases, Department of Pediatrics, University of British Columbia, Vancouver, Canada., Lauffenburger DA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts., Alter G; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University., Levy J; Department of Pediatrics, Hôpital Saint-Pierre, Brussels., Marchant A; Institute for Medical Immunology, Université libre de Bruxelles, Charleroi, Belgium.
Jazyk: angličtina
Zdroj: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2019 May 30; Vol. 68 (12), pp. 2158.
DOI: 10.1093/cid/ciy1058
Databáze: MEDLINE